Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and steering patients toward higher-cost insulin products to increase their profits.
FTC Sues Prescription Drug Middlemen Including CVS for Artificially Inflating Insulin Drug Prices
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx (a CVS company), Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price
FTC sues pharmacy insurance managers, alleging unfair drug prices
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.
American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
FTC goes after drug middlemen for allegedly jacking up insulin prices
The Big Three handle at least 80% of the country’s insulin prescriptions. The price of insulin has exponentially increased in recent years. Now, the Federal Trade Commission (FTC) is suing three companies over allegedly inflating the cost of the drug at the expense of Americans who rely on it.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
Federal Trade Commission finds social and video streaming services pose serious privacy risks
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
JD Supra5d
Non-Compete Contracts: Legally Undead
Contracts restraining competition by former employees and contractors have always faced enforcement headwinds, differing ...
Personal Loan Scams to Watch Out For
Some personal loan offers can be scams. This article will highlight the warning signs to watch out for to avoid losing money ...
The Atlantic26d
The Last-Minute Curveball for a Big FTC Ban
In the early days of 2023, the Federal Trade Commission made a big announcement ... Senator Elizabeth Warren and Representative Matt Gaetz, for example, both came out as strong supporters of ...
Hosted on MSN1d
'It's A Win, But It's Not A Win': Chris Hartman Ace Positive Dismissed By FTC
The loss of accreditation at the University of Kentucky and University of Illinois testing labs played a role in the ...
FTC urged to make smart devices say how long they will be supported
The letter suggests FTC guidance that the authors believe could help shoppers decide if a smart gadget is worth investing in.
‘Project Amelia’: Amazon’s new AI assistant will advise sellers and act on their behalf
Dharmesh Mehta, Amazon VP of Worldwide Selling Partner Services. (GeekWire File Photo /) Amazon is launching a new AI-powered ...
Does your new or used car need an extended warranty? Here are the pros and cons.
Undercoffler said if you do want to buy an extended warranty at the point of your car purchase, you can use it as part of the ...